Revenue of the OTC pharmaceuticals industry Indonesia 2020-2029

The revenue in the OTC pharmaceuticals market in Indonesia was forecast to continuously increase between 2024 and 2029 by in total 1.4 billion U.S. dollars (+46.51 percent). After the ninth consecutive increasing year, the indicator is estimated to reach 4.4 billion U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the OTC pharmaceuticals market was continuously increasing over the past years. The Statista Market Insights cover a broad range of additional markets.

在2024年至2029年期间，印度尼西亚非处方药品市场收入预计将持续增长，总计增长14亿美元（增长46.51%）。在连续九年的增长之后，该指标预计将在2029年达到44亿美元，从而创下新的历史最高点。值得注意的是，在过去几年中，非处方药品市场的收入一直呈持续增长态势。Statista市场洞察涵盖了广泛的其他市场。